This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. shed 4.6% to $33.90 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 43,461.21 and the NASDAQ Composite Index falling 1.2% to 19,286.92.
Moderna Inc. closed 80.1% below its 52-week high of $170.47, which the company achieved on May 24th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.9% to $163.74, Pfizer Inc. rose 1.3% to $26.65, and Gilead Sciences Inc. rose 0.98% to $111.03.
Trading volume totaled 8.8 million, compared to the 50-day average of 11.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 24, 2025 16:35 ET (21:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。